Current Drug Delivery
Title:Meet Our Editor-in-Chief
Volume: 14 Issue: 4
Author(s): Xing-Jie Liang*
Affiliation:
- CAS Center for Excellence in Nanoscience, Laboratory of Controllable Nanopharmaceuticals, Key Lab for Bio-effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Chinese Academy of Sciences, No. 11, First North Road, Zhongguangcun, Beijing, 100190,China
Export Options
About this article
Cite this article as:
Liang Xing-Jie*, Meet Our Editor-in-Chief, Current Drug Delivery 2017; 14 (4) . https://dx.doi.org/10.2174/156720181404170705180425
DOI https://dx.doi.org/10.2174/156720181404170705180425 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Is Hyperhomocyst(e)inemia A Humoral Predictor of Coronary Heart Disease?
Current Pharmaceutical Design Evaluation of Two Fast Virtual Stenting Algorithms for Intracranial Aneurysm Flow Diversion
Current Neurovascular Research Evaluation of Differentiation Quality of Several Differentiation Inducers of Bone Marrow-derived Mesenchymal Stem Cells to Nerve Cells by Assessing Expression of Beta-tubulin 3 Marker: A Systematic Review
Current Stem Cell Research & Therapy Evidence of Lifestyle Modification in the Management of Hypercholesterolemia
Current Cardiology Reviews Ximelagatran - A Promising New Drug in Thromboembolic Disorders
Current Pharmaceutical Design An update on the Management and Treatment of Deep Vein Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Status of Therapeutic Angiogenesis with Protein, Gene and Cell Therapy
Current Drug Therapy Blood Pressure and Childhood Obesity
Current Hypertension Reviews Peripheral Arterial Disease: A Missed Opportunity to Administer Statins so as to Reduce Cardiac Morbidity and Mortality
Current Medicinal Chemistry Burkholderia mallei and Burkholderia pseudomallei: The Causative Micro-organisms of Glanders and Melioidosis
Recent Patents on Anti-Infective Drug Discovery Depression and Medication Adherence in Patients on Hemodialysis
Current Hypertension Reviews Organoselenium Compounds as Potential Neuroprotective Therapeutic Agents
Current Organic Chemistry Adiponectin as a Regulator of Vascular Redox State: Therapeutic Implications
Recent Patents on Cardiovascular Drug Discovery Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome
Current Pharmacogenomics and Personalized Medicine Achieving Secure, Flexible, Effective and Privacy Preserving Data Access Control in Cloud Computing
Recent Patents on Computer Science Progress in the Field of GPIIb/IIIa Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Adipobiology for Novel Therapeutic Approaches in Metabolic Syndrome
Current Vascular Pharmacology Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation
CNS & Neurological Disorders - Drug Targets SUBJECT INDEX
Current Neuropharmacology Anaemia, Polycythaemia and Chronic Heart Failure
Current Cardiology Reviews